Operating Cash Flow
Vertex Pharmaceuticals Operating Cash Flow increased by 186.8% to $1.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 74.4%, from $818.90M to $1.43B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 6.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $927.20M | $995.00M | $956.20M | $1.14B | $955.50M | $1.08B | $899.90M | $1.13B | $1.27B | $234.60M | $1.31B | -$3.75B | -$123.15M | -$123.15M | $818.90M | $1.07B | $1.24B | $498.00M | $1.43B |
| QoQ Change | — | — | +7.3% | -3.9% | +19.2% | -16.2% | +12.9% | -16.6% | +26.1% | +11.8% | -81.5% | +456.9% | -387.3% | +96.7% | +0.0% | +765.0% | +31.0% | +15.7% | -59.9% | +186.8% |
| YoY Change | — | — | — | — | — | +3.1% | +8.4% | -5.9% | -0.5% | +32.7% | -78.2% | +45.2% | -430.9% | -109.7% | -152.5% | -37.3% | +128.6% | >999% | +504.4% | +74.4% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's operating cash flow?
- Vertex Pharmaceuticals (VRTX) reported operating cash flow of $1.43B in Q1 2026.
- How has Vertex Pharmaceuticals's operating cash flow changed year-over-year?
- Vertex Pharmaceuticals's operating cash flow increased by 74.4% year-over-year, from $818.90M to $1.43B.
- What is the long-term trend for Vertex Pharmaceuticals's operating cash flow?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's operating cash flow has grown at a 6.3% compound annual growth rate (CAGR), from $2.84B to $3.63B.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.